This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen.
Diabetes care, 48(9), 1607-1611
Citation
Eldor, Roy; Avraham, Noa; Rosenberg, Orit; Shpigelman, Miriam; Golan-Cohen, Avivit; Cukierman-Yaffe, Tali; Merzon, Eugene; Buch, Assaf. (2025). Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen.. Diabetes care, 48(9), 1607-1611. https://doi.org/10.2337/dc25-0690